Figures & data
Table 1 Baseline Characteristics of Patients Before and After IPTW
Figure 2 Metabolic characteristics of patients in the CHB-MAFLD group. In the CHB-MAFLD group, the proportions of patients with BMI ≥ 23 kg/m2, with BMI < 23 kg/m2 and metabolic dysfunctions, with BMI < 23 kg/m2 and DM were 85.64%, 11.83%, and 2.53%, respectively (A), while 82.53% of these CHB-MAFLD patients had at least one metabolic risk factor (B).
![Figure 2 Metabolic characteristics of patients in the CHB-MAFLD group. In the CHB-MAFLD group, the proportions of patients with BMI ≥ 23 kg/m2, with BMI < 23 kg/m2 and metabolic dysfunctions, with BMI < 23 kg/m2 and DM were 85.64%, 11.83%, and 2.53%, respectively (A), while 82.53% of these CHB-MAFLD patients had at least one metabolic risk factor (B).](/cms/asset/8d38fb5d-556c-4a84-acad-9ef485e331b4/dmso_a_369824_f0002_c.jpg)
Figure 3 Cumulative incidence of cirrhosis per year after IPTW. The different weighted cumulative incidence of cirrhosis per year between the CHB-MAFLD group and the CHB group after IPTW.
![Figure 3 Cumulative incidence of cirrhosis per year after IPTW. The different weighted cumulative incidence of cirrhosis per year between the CHB-MAFLD group and the CHB group after IPTW.](/cms/asset/cd1cddbf-0ab1-4361-92fd-e63fddb6b2f2/dmso_a_369824_f0003_c.jpg)
Figure 4 Cumulative incidence of cirrhosis after IPTW. The cumulative incidence of cirrhosis in the CHB-MAFLD group was significantly higher than that in the CHB group (12.6% and 7.1%, respectively, P=0.015).
![Figure 4 Cumulative incidence of cirrhosis after IPTW. The cumulative incidence of cirrhosis in the CHB-MAFLD group was significantly higher than that in the CHB group (12.6% and 7.1%, respectively, P=0.015).](/cms/asset/916f88a4-c26c-4108-a798-d559280c0aeb/dmso_a_369824_f0004_c.jpg)
Figure 5 Cumulative incidence of cirrhosis after IPTW, by antiviral treatment status.
![Figure 5 Cumulative incidence of cirrhosis after IPTW, by antiviral treatment status.](/cms/asset/ed7ceee3-7d10-429f-bf02-937126096040/dmso_a_369824_f0005_c.jpg)
Table 2 Weighted Univariate and Multivariate Cox Analysis of Risk Factors Related to Cirrhosis After IPTW
Figure 6 Subgroup analysis of cirrhosis risk after IPTW, by antiviral treatment status.
![Figure 6 Subgroup analysis of cirrhosis risk after IPTW, by antiviral treatment status.](/cms/asset/fe7722ab-8fb3-4185-9a92-36490c1a6569/dmso_a_369824_f0006_c.jpg)